Coca-Cola HBC-Srbija d.o.o.:企業の戦略・SWOT・財務分析

◆英語タイトル:Coca-Cola HBC-Srbija d.o.o. - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY5251
◆発行会社(調査会社):MarketLine
◆発行日:2020年3月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:セルビア
◆産業分野:Consumer Packaged Goods
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Coca-Cola HBC-Srbija d.o.o. – Strategy, SWOT and Corporate Finance Report
Summary

Coca-Cola HBC-Srbija d.o.o. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Coca-Cola HBC-Srbija doo (Coca-Cola HBC-Serbia), is a subsidiary of Coca-Cola HBC AG, operates as a franchised bottler of The Coca-Cola Company. The company manufactures and distributes a wide range of non-alcoholic beverages, which are trademark products of The Coca-Cola Company. Its product portfolio includes carbonated drinks, still beverages and packaged water. The company’s products are marketed under various leading brands including Coca – Cola, Coca – Cola Zero, Fanta, Sprite; local brands such as next, Rosa, Joy and brands of other companies such as Nestea, Monster Energy, Schweppes and Ultra Energy. It has bottling plants in Zemun and Vlasinka. Coca-Cola HBC-Srbija is headquartered in Zemun, Serbia.

Scope

- Detailed information on Coca-Cola HBC-Srbija d.o.o. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Coca-Cola HBC-Srbija d.o.o. in the form of a SWOT analysis
- An in-depth view of the business model of Coca-Cola HBC-Srbija d.o.o. including a breakdown and examination of key business segments
- Intelligence on Coca-Cola HBC-Srbija d.o.o.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Coca-Cola HBC-Srbija d.o.o., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of Coca-Cola HBC-Srbija d.o.o. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Coca-Cola HBC-Srbija d.o.o. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Coca-Cola HBC-Srbija d.o.o.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Coca-Cola HBC-Srbija d.o.o.: Company Overview
Coca-Cola HBC-Srbija d.o.o.: Overview and Key Facts
Coca-Cola HBC-Srbija d.o.o.: Overview
Coca-Cola HBC-Srbija d.o.o.: Key Facts
Coca-Cola HBC-Srbija d.o.o.: Key Employees
Coca-Cola HBC-Srbija d.o.o.: Major Products and Services
Coca-Cola HBC-Srbija d.o.o.: Company History
Coca-Cola HBC-Srbija d.o.o.: Management Statement
Coca-Cola HBC-Srbija d.o.o.: Locations and Subsidiaries
Coca-Cola HBC-Srbija d.o.o.: Key Competitors
Coca-Cola HBC-Srbija d.o.o.: Company Analysis
Coca-Cola HBC-Srbija d.o.o.: Business Description
Coca-Cola HBC-Srbija d.o.o.: SWOT Analysis
Coca-Cola HBC-Srbija d.o.o.: SWOT Overview
Coca-Cola HBC-Srbija d.o.o.: Strengths
Coca-Cola HBC-Srbija d.o.o.: Weaknesses
Coca-Cola HBC-Srbija d.o.o.: Opportunities
Coca-Cola HBC-Srbija d.o.o.: Threats
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Coca-Cola HBC-Srbija d.o.o.: Key Facts
Table 2: Coca-Cola HBC-Srbija d.o.o.: Key Employees
Table 3: Coca-Cola HBC-Srbija d.o.o.: Company History
Table 4: Coca-Cola HBC-Srbija d.o.o.: Locations and Subsidiaries
Table 5: Coca-Cola HBC-Srbija d.o.o.: Key Competitors

★海外企業調査レポート[Coca-Cola HBC-Srbija d.o.o.:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lincoln Electric Holdings Inc:企業の戦略・SWOT・財務分析
    Lincoln Electric Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Lincoln Electric Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • OTE Group:企業の戦略・SWOT・財務分析
    OTE Group - Strategy, SWOT and Corporate Finance Report Summary OTE Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Cardinal Ethanol LLC (CRDE):企業の戦略的SWOT分析
    Cardinal Ethanol LLC (CRDE) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Sihuan Pharmaceutical Holdings Group Ltd (460):企業の財務・戦略的SWOT分析
    Summary Sihuan Pharmaceutical Holdings Group Ltd (Sihuan Pharmaceutical) is a pharmaceutical company that develops, manufactures and markets prescription drugs. The company offers products in the therapeutic areas of cardio-cerebral vascular system, central nervous system, metabolism, oncology and a …
  • IXICO Plc (IXI)-製薬・医療分野:企業M&A・提携分析
    Summary IXICO Plc (IXICO), formerly Phytopharm plc is a provider of clinical trial services and technology for the evaluation of imaging endpoints. The company provides clinical trial services for assessing the safety and efficacy of drugs. Its product portfolio includes web-based platform to transf …
  • Terex Corporation:企業のM&A・事業提携・投資動向
    Terex Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Terex Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • ADC Therapeutics SA:製薬・医療:M&Aディール及び事業提携情報
    Summary ADC Therapeutics SA (ADCT) is a pharmaceutical company that develops a pipeline of proprietary antibody drug conjugates for the treatment of both solid and hematological cancers. The company offers combining monoclonal antibodies specific to particular types of tumor cells with a novel class …
  • Avcorp Industries Inc:企業の戦略・SWOT・財務情報
    Avcorp Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Avcorp Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • UniQuest Pty Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary UniQuest Pty Ltd (UniQuest), a subsidiary of The University of Queensland is a commercialization company that offers consultancy services. The company commercializes intellectual property and research outcomes of University of Queensland. It offers services such as eShop, witness, contract r …
  • InVivoScribe Technologies Inc:企業の製品パイプライン分析
    Summary InVivoScribe Technologies Inc (InVivoScribe) is a provider of hematology-oncology testing products and services. The company offer full range of hematology-oncology testing products and services. It’s products include lymphotrack and lymphotrack DX assay kits, and custom assay and reagent de …
  • Strongbridge Biopharma plc (SBBP)-製薬・医療分野:企業M&A・提携分析
    Summary Strongbridge Biopharma plc (Strongbridge), formerly Cortendo plc, is a commercial-stage biopharmaceutical company that develops and commercializes therapies for rare diseases. The company’s marketed product, KEVEYIS (dichlorphenamide), is indicated for the treatment of hyperkalemic, hypokale …
  • FLYHT Aerospace Solutions Ltd.:企業の戦略・SWOT・財務分析
    FLYHT Aerospace Solutions Ltd. - Strategy, SWOT and Corporate Finance Report Summary FLYHT Aerospace Solutions Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Orbis Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Orbis Biosciences Inc (Orbis) is a developer of pharmaceutical products that offers optimizes oral and injectable products. The company provides preclnical pipeline indications for pathologies including cancer, bronchiolitis, Eczema, atopic dermatitis, nephrotic syndrome, HIV, asthma, bunine …
  • Saline Water Conversion Corp:企業の戦略的SWOT分析
    Saline Water Conversion Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Spritzer Bhd:企業の戦略・SWOT・財務情報
    Spritzer Bhd - Strategy, SWOT and Corporate Finance Report Summary Spritzer Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Taylor-DeJongh Inc:企業の戦略・SWOT・財務分析
    Taylor-DeJongh Inc - Strategy, SWOT and Corporate Finance Report Summary Taylor-DeJongh Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sekisui House, Ltd.:企業の戦略・SWOT・財務情報
    Sekisui House, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sekisui House, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Sypris Solutions, Inc.:企業の戦略・SWOT・財務分析
    Sypris Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sypris Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Karyopharm Therapeutics Inc (KPTI):企業の財務・戦略的SWOT分析
    Karyopharm Therapeutics Inc (KPTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • EBOS Group Ltd (EBO):製薬・医療:M&Aディール及び事業提携情報
    Summary EBOS Group Ltd (EBOS) is a healthcare products supplier that markets, sells and distributes healthcare, medical and pharmaceutical products. It also markets and distributes animal care products and offers distribution, warehousing and logistics support to pharmaceutical manufacturers and med …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆